Drug intelligence / Profile preview

sakuranetin

Development stage
Preclinical
Modality
Small Molecules
01

Overview

Sakuranetin is a naturally occurring methoxylated flavanone classified as a flavonoid phytoalexin. It is found in various plants such as rice and Polyomnia fruticosa, where it acts as a defense compound against pathogens. Sakuranetin exhibits diverse biological activities including strong antifungal and antiviral effects, anti-inflammatory and antioxidative properties, and potential benefits in models of acute lung injury, asthma, colitis, and neurodegenerative diseases like Alzheimer’s disease. Mechanistically, sakuranetin modulates inflammatory pathways by inhibiting mitogen‐activated protein kinases (MAPKs), STAT3-SOCS3 signaling pathways, Th2/Th17 cytokines production, cyclooxygenase enzymes COX1/COX2 activity inhibition at high concentrations in vitro, and may influence gut microbiota composition to improve intestinal immune balance[1][3][5][7][10]. It is not an approved pharmaceutical drug but is used experimentally for research purposes.

Other names
Naringenin 7-methyl etherNaringenin7-methyl etherNaringenin-7-methyl ether7-O-Methylnaringenin5,4'-Dihydroxy-7-methoxyflavanone(S)-(-)-4',5-dihydroxy-7-methoxyflavanoneSAKURANETIN [MI]EINECS 220-980-5EINECS220-980-5EINECS-220-980-5(2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-chroman-4-oneFlavanone, 4',5-dihydroxy–7-methoxy-, (S)-(−)Sakura Pavilion
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)MEKSTAT3 (Signal Transducer and Activator of Transcription 3)

Beyond the preview

Go deeper on sakuranetin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sakuranetin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call